Evaluation of point-of-care lactate measurement as a prognostic tool in critically ill patients: correlation with sepsis severity and ICU outcomes

Project Abstract

In the era of increasing critical care demands, rapid and accurate prognostication remains pivotal for optimizing therapeutic strategies and resource allocation in septic and critically ill patients. This study evaluates the utility of point-of-care (POC) lactate measurement as a prognostic biomarker, examining its correlation with sepsis severity and ICU outcomes. A prospective cohort of adult patients admitted to the ICU with suspected or confirmed sepsis was enrolled over a 12-month period. Lactate levels were measured using validated POC devices at admission, then serially at 6, 12, and 24 hours, alongside standard laboratory lactate assays for cross-validation. Sepsis severity was categorized using established scoring systems including the Sequential Organ Failure Assessment (SOFA) and the Acute Physiology and Chronic Health Evaluation II (APACHE II). Primary outcomes included ICU mortality, length of ICU stay, and need for vasopressor support; secondary outcomes encompassed duration of mechanical ventilation, incidence of organ dysfunction, and time to lactate clearance (defined as a return to within reference range or a 10% decrease from baseline within 6 hours). Data analysis employed multivariate Cox proportional hazards models to assess the independent prognostic value of initial and serial POC lactate levels, adjusting for age, comorbidities, source of infection, and baseline organ function. Receiver operating characteristic (ROC) curve analysis determined the discriminative ability of POC lactate for predicting ICU mortality and high SOFA scores. Correlation analyses evaluated agreement between POC and central laboratory lactate measurements, with Bland-Altman plots and intraclass correlation coefficients (ICC) used to quantify concordance. Subgroup analyses explored performance differences across septic shock vs. non-shock sepsis, diabetic status, and renal impairment. Results demonstrated that elevated initial POC lactate was significantly associated with higher SOFA scores and greater likelihood of ICU mortality (p<0.001). Serial lactate trajectories provided incremental prognostic information, with slower lactate clearance correlating with prolonged ICU stays and increased vasopressor dependence. The area under the ROC curve for initial POC lactate predicting ICU mortality was robust (AUC 0.78; 95% CI 0.72–0.84), improving with serial measurements (AUC at 6 hours 0.82; 95% CI 0.76–0.88; at 24 hours 0.85; 95% CI 0.79–0.90). POC lactate showed good agreement with central laboratory assays (ICC = 0.89; mean difference ?0.2 mmol/L, 95% limits of agreement ±0.6 mmol/L). After adjustment, initial POC lactate remained an independent predictor of ICU mortality (hazard ratio 1.32 per 1 mmol/L increase; 95% CI 1.15–1.52). Subgroup analyses highlighted greater prognostic value in patients with septic shock and those without chronic kidney disease. The findings support the integration of POC lactate measurement into early risk stratification protocols for critically ill patients, offering rapid, bedside prognostication that aligns closely with traditional laboratory metrics while enabling timely therapeutic decisions. Limitations include single-center design and potential operator variability in POC testing, underscoring the need for multicenter validation and standardized training to optimize implementation in diverse ICU settings.

Project Overview

What This Project Is About

---

A simple, no-frills look at how measuring lactate at the patient’s bedside (point-of-care testing) might help doctors predict illness severity and outcomes in people who are critically ill, especially those with sepsis. The project explores whether higher lactate levels relate to worse organ function, longer hospital stays, or higher chances of needing intensive care.

---

---

The Problem It Addresses

---

Doctors often need quick clues about how sick a patient is. Traditional lab tests can take time, and a fast bedside lactate test might provide early warning signs of deterioration. If lactate measurements can reliably predict who will require intensive care or have poorer outcomes, care can be started sooner and more effectively.

---

---

Objectives of the Project

---

1. Understand what lactate is and why it rises in severe illness.
2. Evaluate how bedside lactate measurements relate to sepsis severity.
3. Explore the link between lactate levels and ICU outcomes like length of stay and mortality.
4. Assess the practicality and limitations of point-of-care lactate testing in clinical settings.

---

---

What You Will Do Step by Step

---

1. Review basic concepts about lactate and sepsis. 2. Collect de-identified patient data or summaries from a clinic or hospital setting where bedside lactate tests were used. 3. Compare lactate results with sepsis severity scores and ICU outcomes. 4. Use simple statistical methods to look for relationships. 5. Discuss what the results could mean for patient care and future research.

---

---

Expected Outcome

Expected to find a meaningful link between higher bedside lactate levels and worse sepsis severity or ICU outcomes, along with practical recommendations on when to use the test and its limitations in everyday care.